Ingredients & Clinicals
How We Talk About Our Science
The honest way to share what SeneGence products do — and why the honesty is the advantage.
card 01
We love the science — and we keep it honest
for the marketer
We talk about what you can see and feel: glow, smoothness, a firmer-looking finish. That honesty is the advantage.
for the professional
One frame runs through everything you say about a SeneGence product: describe appearance, and cite the study behind it.
SeneGence products are cosmetics — they improve how skin looks. So we talk about the look of firmness, the feel of smoothness, a radiant finish. When we share a clinical result, we name what it measured and who ran it.
Precision is not a limitation; it earns trust. Vague hype is forgettable; a sourced claim makes the sale.
for the skintellectual
This track follows one habit: describe what you SEE, and cite the study. This card is the source; elsewhere, a result footnotes back here instead of re-explaining.
The reason is a legal line. US law defines a cosmetic as an article intended to cleanse, beautify, or improve appearance. A drug is anything intended to affect the body's structure or function, or to treat a condition. Same jar of cream — the words decide the category. Say a product makes skin look firmer and it is a cosmetic; say it builds collagen and you have described an unapproved drug.
Our clinicals are real, independent, and strong, so we never overstate them. We share the number, name the lab, and let the honesty persuade — warm, specific, never promising to change your biology.
card 02
Cosmetic, not drug — the line every word walks
for the marketer
A cosmetic improves how skin looks. A drug changes your body. We are a cosmetic, so we describe appearance, never treatment.
for the professional
The distinction lives in the verb. Appearance verbs are safe: looks firmer, appears smoother, more radiant. Structure/function verbs are drug claims: repairs, regenerates, treats, produces collagen, reactivates fibroblasts.
So we translate the mechanism into what you can see. "Renews cells" becomes "skin looks fresher."
for the skintellectual
The FDA distinction (FD&C Act) turns on intended use, read from your words, not the formula. The moment a claim says the product changes the body's structure or function — or treats, prevents, or cures a condition — it is an unapproved drug, and the distributor and the company both carry the risk.
So these translations are mandatory, not optional softening:
Keep the poetic ideas — an ingredient can "re-open the conversation between skin's layers." Just stop before the physiological payoff. And never revive retired figures from older marketing; cite only currently substantiated numbers, with their study line.
card 03
Two layers: the ingredient may carry the science; the product stays appearance
for the marketer
The ingredient can carry its lab science. The product we describe by what you see and feel. Two layers, one honest story.
for the professional
Two legal objects, two rules. The ingredient (INCI molecule) may carry attributed lab science — you describe a molecule documented by supplier data, not a promise the jar performs it. The product stays appearance-only: what you see and feel.
for the skintellectual
This move honors both the science and the law. There are two legal objects.
An ingredient is a molecule, and the science about it is documented by its source — supplier dossiers, INCI data, laboratory studies. Describing what the molecule is shown in laboratory studies to do is lawful and encouraged; it justifies a premium formula. A finished cosmetic is a drug or not by its intended use, which the FDA reads from the totality of your words. So the product stays at appearance: what you see and feel.
The whole distinction is one framing move:
So go deep on the ingredient, then close on the product boundary: "in the finished cosmetic we describe only the visible result."
card 04
We're educators, not doctors
for the marketer
We are product experts, not physicians. We never diagnose, prescribe, or promise to change your body — we teach what our products do.
for the professional
We know the ingredients, routines, and studies cold. What we do not do is practice medicine: we never diagnose a skin condition, prescribe a remedy, or promise a change inside the body.
So a dry patch is "skin that looks dehydrated," not eczema. A breakout is "congested-looking skin," not acne we will "clear up."
for the skintellectual
The educator posture is both an ethical stance and a legal safeguard. "Diagnose," "treat," "prescribe," and "cure" are the vocabulary of medicine. Using them re-frames a cosmetic sale as unlicensed medical advice on top of an unapproved drug claim — compounding the exposure.
Stay descriptive. You may explain, in general terms, how skin works — teaching the barrier or the renewal cycle is lawful and valuable. The violation appears only when an outcome gets attached to a product as a bodily action: "this treats your rosacea," "this repairs your barrier." Teach the biology in the abstract; describe the product by appearance.
card 05
One study, one product — the scope rule
for the marketer
A study measured one tested product — so its number belongs to that product, not to everything that shares the ingredient.
for the professional
A clinical result describes the specific article tested, not every product sharing an ingredient. Our SenePlex+ stat is the example:
for the skintellectual
The scope rule is where good intentions slip. SenePlex+ is in many products, so it is tempting to attach its best number to all of them. But the Essex study measured one formulation, in one Evening Moisturizer, on 33 subjects. The result belongs to that article as tested — full stop. Transferring it to a lip color or a serum that shares the complex is an unsubstantiated claim, even though the ingredient is present.
Two more precision habits keep us clean: